Finance

Lists
Q3 2026 earnings • released • EPS beat +11.19% • Revenue beat +6.66%
See results
CLS:NYSE
Celestica Inc
$246.65
-5.03%
(-13.07) 1D
$285.53
+15.76% (+38.88)
After hours
Closed: Oct 26, 4:03:34 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLS...
Open
$267.00
High
$273.14
Low
$246.24
Mkt. cap
31.12B
Avg. vol.
2.21M
Volume
6.17M
P/E ratio
25.64
52-wk high
$474.02
52-wk low
$244.51
EPS
$9.62
Beta
2.01
Shares outstanding
124.66M
No. of employees
24K
Open
$267.00
High
$273.14
Low
$246.24
Mkt. cap
31.12B
Avg. vol.
2.21M
Volume
6.17M
P/E ratio
25.64
52-wk high
$474.02
52-wk low
$244.51
EPS
$9.62
Beta
2.01
Shares outstanding
124.66M
No. of employees
24K
News stories
From web sources and news partners
Profile
Celestica Inc. is a Canadian multinational design, manufacturing, hardware platform, and supply chain electronics manufacturing services company, which is headquartered in Toronto, Ontario. The company operates in 50 sites across 15 countries. Wikipedia
About Celestica Inc
CEORobert A. Mionis
Employees23.8K
Founded1994
HeadquartersToronto, Ontario, Canada
SectorElectronics manufacturing services
Websitecelestica.com
Analyst ratings
Based on 15 analysts giving stock ratings to CLS in the past 3 months
Strong buy
Buy
15
Hold
0
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for CLS in the last 3 months.
Highest
Current $246.65
$535.00 (+116.91%)
Average
$465.40 (+88.69%)
Lowest
$375.00 (+52.04%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Vogt
UBS
Buy
Maintained
$430.00
+74.3%
10/16/2026
Daniel Zhu‏
Bernstein
Buy
Maintained
$520.00
+110.8%
10/14/2026
Todd Coupland
CIBC
Buy
Maintained
$500.00
+102.7%
10/08/2026
Unknown Analyst
Bernstein
Buy
Initiated
CA$520.00
+110.8%
09/30/2026
Chris Krueger CFA
TD Cowen
Buy
Maintained
$430.00
+74.3%
09/16/2026
John Shao
TD Cowen
Buy
Maintained
$430.00
+74.3%
09/16/2026
Shebly Seyrafi
FBN Securities
Buy
Initiated
$375.00
+52%
09/15/2026
Mehdi Hosseini
Susquehanna
Buy
Reiterated
$535.00
+116.9%
09/12/2026
Kevin Krishnaratne
Scotiabank
Buy
Maintained
$500.00
+102.7%
09/03/2026
Paul Treiber
RBC Capital
Buy
Maintained
$450.00
+82.4%
08/26/2026
Tim Long
Barclays
Buy
Maintained
$406.00
+64.6%
08/07/2026
Thanos Moschopoulos
BMO Capital
Buy
Maintained
$450.00
+82.4%
07/28/2026
Jim Kelleher
Argus Research
Buy
Reiterated
$450.00
+82.4%
07/28/2026
Unknown Analyst
Argus Research
Buy
Reiterated
$450.00
+82.4%
07/28/2026
George Notter
Wolfe Research
Buy
Reiterated
$475.00
+92.6%
07/28/2026
Joseph Cardoso
J.P. Morgan
Buy
Reiterated
$485.00
+96.6%
07/29/2026
Michael Ng
Goldman Sachs
Buy
Maintained
$475.00
+92.6%
07/27/2026
Ruben Roy
Stifel Nicolaus
Buy
Maintained
$500.00
+102.7%
07/28/2026
Nilesh Bhaiya
Citi
Buy
Maintained
$475.00
+92.6%
05/26/2026
Mike Ng
Goldman Sachs
Buy
Maintained
$475.00
+92.6%
05/26/2026
Mike Harrison
Rothschild & Co Redburn
Buy
Initiated
$460.00
+86.5%
05/01/2026
Ruplu Bhattacharya
Bank of America Securities
Buy
Reiterated
$490.00
+98.7%
04/30/2026
Samik Chatterjee
J.P. Morgan
Buy
Reiterated
$425.00
+72.3%
04/29/2026
Atif Malik
Citi
Buy
Maintained
$415.00
+68.3%
04/29/2026
Unknown Analyst
Canaccord Genuity
Buy
Maintained
$500.00
+102.7%
04/29/2026
Last report
Just released
Today, 2:00 PM
Fiscal period
Q3 2026
$3.30 / $2.97
+11.19%beat
Revenue / Est. (USD)
5.83B / 5.47B
+6.66%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.19B
3.65B
4.05B
4.70B
Cost of goods sold
2.78B
3.22B
3.61B
4.12B
Cost of revenue
2.78B
3.22B
3.61B
4.12B
Research and development expenses
36.40M
30.20M
41.20M
46.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
38.60M
71.30M
117.20M
58.00M
Operating expense
86.40M
114.90M
169.30M
116.20M
Total operating expenses
2.86B
3.34B
3.78B
4.24B
Operating income
329.70M
318.20M
267.90M
461.30M
Other non operating income
-
-
-
-
EBT including unusual items
310.90M
301.30M
256.30M
441.60M
EBT excluding unusual items
315.80M
304.60M
251.90M
443.90M
Income tax expense
43.10M
33.80M
44.00M
72.80M
Effective tax rate
13.86%
11.22%
17.17%
16.49%
Other operating expenses
-
1.40M
-
-
Net income
267.80M
267.50M
212.30M
368.80M
Net profit margin
8.38%
7.32%
5.25%
7.85%
Earnings per share
1.58
1.89
2.16
2.54
Interest and investment income
-
-
-
3.80M
Interest expense
-13.90M
-13.60M
-16.00M
-21.20M
Net interest expenses
-13.90M
-13.60M
-16.00M
-17.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
370.00M
370.90M
307.50M
505.30M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps